-transparent.png){kind=logo}
Human peripheral blood neutrophils (PMN) treated with granulocyte-macrophage CSF (GM-CSF) increase the amount of class I 42-kDa H chain and 12-kDa L chain, beta 2-microglobulin (beta 2m), that they synthesize by 2.1- and 2.6-fold, respectively. To determine whether the increase in translation was associated with an increase in levels of class I H chain transcript, RNA blot analysis was performed on PMN that had been cultured in the presence of GM-CSF. Under no conditions were there increased levels of class I H chain transcript when class I heterodimer protein synthesis was increased. In addition, there was neither an increase in the synthesis of H chain mRNA, as measured by transcription assay, nor an alteration in the degradation rates of class I H chain transcript in PMN cultured with GM-CSF. In situ hybridization demonstrated that both the percentage of PMN that expressed class I transcript and the relative amounts of transcript per cell in GM-CSF-cultured PMN were the same as those in control PMN. Although there is increased translation of class I heterodimer in PMN treated with GM-CSF, there is no increase in its expression on the plasma membrane. The maintenance of constant levels of class I on the plasma membrane is dependent on continued protein synthesis and is maintained by release of class I heterodimer and free beta 2m into the medium. Heterodimer is released in the context of plasma membrane-derived vesicles, whereas beta 2m is released as a soluble protein. Maintenance of constant levels of class I heterodimer on the plasma membrane is also regulated by constitutive internalization. Up to 30% of class I molecules bearing 125I-Fab-labeled mAb to class I are internalized over 2 h at 37 degrees C. Therefore, inducible synthesis of class I by PMN is likely a consequence of post-transcriptional regulation, whereas the continued synthesis of class I heterodimer is required for maintenance of its expression. Furthermore, there is no increase in class I expression, in spite of increased synthesis, due to the release of class I heterodimer and beta 2m and the internalization of class I heterodimer from the plasma membrane. Thus, PMN are capable of post-transcriptional regulation of protein synthesis and are able to modulate the expression of plasma membrane proteins by regulated expression, release, and internalization.
E Neuman, and
J W Huleatt, and
H Vargas, and
E E Rupp, and
R M Jack
December 2000,
Journal of hematotherapy & stem cell research,
E Neuman, and
J W Huleatt, and
H Vargas, and
E E Rupp, and
R M Jack
April 1993,
Virology,
E Neuman, and
J W Huleatt, and
H Vargas, and
E E Rupp, and
R M Jack
August 1990,
Immunology today,
E Neuman, and
J W Huleatt, and
H Vargas, and
E E Rupp, and
R M Jack
February 2003,
The Journal of general virology,
E Neuman, and
J W Huleatt, and
H Vargas, and
E E Rupp, and
R M Jack
October 1993,
Scandinavian journal of immunology,
E Neuman, and
J W Huleatt, and
H Vargas, and
E E Rupp, and
R M Jack
September 1991,
Journal of reproductive immunology,
E Neuman, and
J W Huleatt, and
H Vargas, and
E E Rupp, and
R M Jack
November 2016,
Cancer immunology research,
E Neuman, and
J W Huleatt, and
H Vargas, and
E E Rupp, and
R M Jack
March 1998,
Experimental & molecular medicine,
E Neuman, and
J W Huleatt, and
H Vargas, and
E E Rupp, and
R M Jack
January 1990,
Critical reviews in immunology,
E Neuman, and
J W Huleatt, and
H Vargas, and
E E Rupp, and
R M Jack
January 1991,
Biotechnology (Reading, Mass.),
